Psychiatry and Neurology, Neurology · New York, NY
NPI
1275538332
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
201 E 15th St
New York, NY, 10003
Phone (212) 260-5060
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
547 services
Medicare patients, 2024
106
Average age 75
Drug cost, 2024
$25K
297 prescriptions
Company payments, 2025
$282
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil S Rosenthal was code 99213 (office e&m - established), 296 times for 88 patients. In total Neil S Rosenthal billed 547 services in 10 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 296 | 88 | $75.62 | $22K |
| 99214 Office E&M - Established | Office | 113 | 59 | $110.66 | $13K |
| 99204 Office E&M - New | Office | 46 | 46 | $140.72 | $6,473 |
| 95886 Electrical Nerve Conductivity | Office | 35 | 17 | $84.36 | $2,953 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 19 | 18 | $168.43 | $3,200 |
| 95816 Neurologic | Office | 18 | 18 | $353.16 | $6,357 |
| 95909 Electrical Nerve Conductivity | Office | 13 | 12 | $117.33 | $1,525 |
By year: 2022 $59K for 520 services; 2023 $66K for 580 services; 2024 $56K for 547 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neil S Rosenthal prescribed most often to Medicare patients was Butorphanol Tartrate, with 43 prescriptions and refills. In total Neil S Rosenthal wrote 297 Medicare prescriptions that cost $25K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Butorphanol Tartrate Generic | 43 | 43 | Under 11 | $14K |
| Memantine Hcl Generic | 36 | 70 | Under 11 | $639 |
| Gabapentin Generic | 33 | 57 | Under 11 | $636 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 32 | 94 | Under 11 | $1,071 |
| Donepezil Hcl Generic | 16 | 38 | Under 11 | $83.58 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 14 | 26 | Under 11 | $97.37 |
| Rasagiline Mesylate Generic | 14 | 24 | Under 11 | $1,792 |
| Amantadine Amantadine Hcl | 13 | 35 | Under 11 | $1,417 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 11 | 31 | Under 11 | $308 |
Brand drugs: - claims; generic drugs: 291 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neil S Rosenthal $282 ($282 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $214.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.